<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-antioxidants-09-01191">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Teismann</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Tieu</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Choi</surname>
    <given-names>D.K.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>D.C.</given-names>
   </name>
   <name>
    <surname>Naini</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Hunot</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Vila</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Jackson-Lewis</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Przedborski</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Cyclooxygenase-2 is instrumental in Parkinsonâ€™s disease neurodegeneration</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>2003</year>
  <volume>100</volume>
  <fpage>5473</fpage>
  <lpage>5478</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.0837397100</pub-id>
  <pub-id pub-id-type="pmid">12702778</pub-id>
 </element-citation>
</ref>
